Package Leaflet: Information for the Patient
Dubas25,000 IU Soft Capsules
Colecalciferol (Vitamin D3)
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the package leaflet:
Dubas contains the active substance Colecalciferol, also known as Vitamin D3.
Dubas is indicated for the treatment of vitamin D deficiency in adults.
Dubas is indicated in adults.
Do not takeDubas
Warnings and precautions
Talk to your doctor or pharmacist before you start taking Dubas.
Tell your doctor if you have any of the following conditions, as an increased dose as indicated in section 3 "How to take Dubas" may be necessary:
Children
Dubas should not be administered to babies and children under 18 years of age.
Other medicines and Dubas
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
In particular, consult your doctor if you are taking the following medicines, as they may reduce or increase the effect of Colecalciferol:
Taking Dubas with food and beverages and alcohol
Consult your doctor if you are taking other products that contain vitamin D, vitamin D-enriched foods, or if you are using vitamin D-enriched milk, so that they can take into account the total dose of vitamin D and avoid excessive doses.
Consuming large amounts of alcohol over a long period (chronic alcoholism) decreases vitamin D deposits in the liver.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Dubas should not be used during pregnancy and breastfeeding. However, your doctor may decide that your clinical conditions necessarily require treatment with Colecalciferol in lower doses.
Pregnancy
Your doctor will prescribe vitamin D during the first 6 months of pregnancy only if it is strictly necessary, due to the risk of harmful effects on the fetus (see section 3: "If you take more Dubas than you should").
However, since the lack of vitamin D is harmful to the fetus and the mother, when necessary, your doctor will prescribe vitamin D during pregnancy at lower doses.
Breastfeeding
When necessary, your doctor will prescribe vitamin D at lower doses during breastfeeding. This does not replace the administration of vitamin D to the baby.
Driving and using machines
Colecalciferol has no influence or insignificant influence on the ability to drive and use machines.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
The recommended dose and duration of treatment will be evaluated by your doctor based on your health conditions.
Do not exceed the dose recommended by your doctor.
Take the dose orally.
Take this medicine with food.
The amount of Colecalciferol will depend on your vitamin D levels and response to treatment.
Treatment of vitamin D deficiency (initial dose) in adults: 1 capsule every week.
After the first month of treatment, your doctor should consider a lower maintenance dose depending on your condition.
Any additional treatment with Colecalciferol should be decided by your doctor.
If you take moreDubas than you should
If you accidentally take more than the prescribed dose of Colecalciferol, tell your doctor immediately or go to the nearest hospital. In case of overdose, there may be an increase in calcium levels in the blood and urine, whose symptoms are the following: nausea, vomiting, thirst, intense thirst (polydipsia), increased urine production (polyuria), constipation, and dehydration.
Other symptoms of overdose are the following:
Diarrhea, anorexia, fatigue, headache, muscle and joint pain, muscle weakness, kidney stones, nephrocalcinosis, and renal insufficiency.
Chronic excessive overdoses can lead to deposits of calcium salts in blood vessels and organs.
Taking too much vitamin D in the first 6 months of pregnancy can cause serious harm to the fetus and the newborn.
In case of overdose or accidental ingestion, consult the Toxicology Information Service.
Phone 91 562 04 20.
If you forget to take Dubas
Do not take a double dose to make up for forgotten doses.
If you stop takingDubas
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Dubascontains glycerol
May cause headache, stomach upset, and diarrhea.
May cause allergic reactions.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects associated with the use of vitamin D are the following:
Uncommon side effectsthat may affect up to 1 in 100 people:
Allergic reactions, weakness, loss of appetite (anorexia), increased calcium levels in the blood (hypercalcemia) and in the urine (hypercalciuria).
Rare side effectsthat may affect up to 1 in 1,000 people:
Somnolence, confusion, constipation, gas (flatulence), stomach pain, nausea, vomiting, diarrhea, metallic taste, dry mouth, skin rash, itching, hives.
Frequency not known(frequency cannot be estimated from the available data):
Headache, too much calcium in the kidneys (nephrocalcinosis), increased urine production (polyuria), intense thirst (polydipsia), kidney disease (renal insufficiency).
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System of Medicines for Human Use https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Store below 25°C.
Store in the original package to protect from light.
Do not freeze.
Composition ofDubas
Excipients: refined olive oil, butylhydroxytoluene (E321) Capsule shell: glycerol (E422), titanium dioxide (E171), gelatin, and Allura Red (E129).
Appearance of the product and pack contents
The pack contains 1, 2, 4 capsules in a PVC/PVDC and aluminum blister pack, enclosed in a cardboard box.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing Authorisation Holder
Pharmacare Srl
Via Marghera, 29
20149 Milan
Italy
Manufacturer
DOPPEL FARMACEUTICI S.r.l.
Via Martiri delle Foibe, 1
29016 Cortemaggiore (PC)
Italy
This medicine is authorised in the Member States of the EEA under the following names:
Malta: DUBAS 25,000 IU soft capsules
Spain: DUBAS 25,000 IU soft capsules
Date of last revision of this leaflet: November 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/